Emerging and state of the art hemagglutinin-targeted influenza virus inhibitors.
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging and state of the art hemagglutinin-targeted influenza virus inhibitors.
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-14
Publisher
Informa UK Limited
Online
2020-12-18
DOI
10.1080/14656566.2020.1856814
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry
- (2020) Daniel Lauster et al. Nature Nanotechnology
- Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study
- (2019) Ellie Hershberger et al. EBioMedicine
- A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface
- (2019) Sandhya Bangaru et al. CELL
- Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism
- (2019) Akiko Watanabe et al. CELL
- Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope
- (2019) Goran Bajic et al. Cell Host & Microbe
- Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections
- (2019) Mohammad Amin Behzadi et al. Frontiers in Microbiology
- Frustration and fidelity in influenza genome assembly
- (2019) Nida Farheen et al. Journal of the Royal Society Interface
- Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia
- (2019) Mart Toots et al. Science Translational Medicine
- An oligothiophene compound neutralized influenza A viruses by interfering with hemagglutinin
- (2018) Xintian Shen et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses
- (2018) Xin Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil
- (2018) Shinya Omoto et al. Scientific Reports
- Transmissibility and severity of influenza virus by subtype
- (2018) Ji-Eun Park et al. INFECTION GENETICS AND EVOLUTION
- Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin
- (2018) Nick S. Laursen et al. SCIENCE
- Oligothiophene compounds inhibit the membrane fusion between H5N1 avian influenza virus and the endosome of host cell
- (2017) Zhibo Zhu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Aniline-Based Inhibitors of Influenza H1N1 Virus Acting on Hemagglutinin-Mediated Fusion
- (2017) Rosana Leiva et al. JOURNAL OF MEDICINAL CHEMISTRY
- Spatial Screening of Hemagglutinin on Influenza A Virus Particles: Sialyl-LacNAc Displays on DNA and PEG Scaffolds Reveal the Requirements for Bivalency Enhanced Interactions with Weak Monovalent Binders
- (2017) Victor Bandlow et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Potent peptidic fusion inhibitors of influenza virus
- (2017) Rameshwar U. Kadam et al. SCIENCE
- Novel Influenza D virus: Epidemiology, pathology, evolution and biological characteristics
- (2017) Shuo Su et al. Virulence
- Constraints, Drivers, and Implications of Influenza A Virus Reassortment
- (2017) Anice C. Lowen Annual Review of Virology
- Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
- (2016) Nicole L. Kallewaard et al. CELL
- Structure-activity relationships of 3-O-β-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitors
- (2016) Gaopeng Song et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Investigational hemagglutinin-targeted influenza virus inhibitors
- (2016) Li-Yan Zeng et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Nanostructured glycan architecture is important in the inhibition of influenza A virus infection
- (2016) Seok-Joon Kwon et al. Nature Nanotechnology
- Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
- (2016) Rameshwar U. Kadam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications
- (2016) Erin Sparrow et al. VACCINE
- A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
- (2016) Abdul Muheem et al. SAUDI PHARMACEUTICAL JOURNAL
- A DNA Aptamer Against Influenza A Virus: An Effective Inhibitor to the Hemagglutinin–Glycan Interactions
- (2016) Wenkai Li et al. Nucleic Acid Therapeutics
- Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor
- (2016) Qing Chen et al. ACS Infectious Diseases
- Phase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults
- (2015) Jonathan M. Zenilman et al. ANTIVIRAL RESEARCH
- Super short membrane-active lipopeptides inhibiting the entry of influenza A virus
- (2015) Wenjiao Wu et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Inhibitors Targeting the Influenza Virus Hemagglutinin
- (2015) F. Li et al. CURRENT MEDICINAL CHEMISTRY
- Strategies towards universal pandemic influenza vaccines
- (2015) Fang He et al. Expert Review of Vaccines
- A broadly neutralizing human monoclonal antibody is effective against H7N9
- (2015) Kannan Tharakaraman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
- (2015) A. Impagliazzo et al. SCIENCE
- New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides
- (2015) Wenjiao Wu et al. PLoS One
- Arbidol as a broad-spectrum antiviral: An update
- (2014) Julie Blaising et al. ANTIVIRAL RESEARCH
- Peptide entry inhibitors of enveloped viruses: The importance of interfacial hydrophobicity
- (2014) Hussain Badani et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Characterization of a Novel Influenza Virus in Cattle and Swine: Proposal for a New Genus in the Orthomyxoviridae Family
- (2014) B. M. Hause et al. mBio
- Protective Immunity Based on the Conserved Hemagglutinin Stalk Domain and Its Prospects for Universal Influenza Vaccine Development
- (2014) Madhu Khanna et al. Biomed Research International
- Aptamers that bind to the hemagglutinin of the recent pandemic influenza virus H1N1 and efficiently inhibit agglutination
- (2013) Subash C.B. Gopinath et al. Acta Biomaterialia
- Role of the viral hemagglutinin in the anti-influenza virus activity of newly synthesized polycyclic amine compounds
- (2013) Eva Torres et al. ANTIVIRAL RESEARCH
- Sialylneolacto-N-tetraose c (LSTc)-bearing Liposomal Decoys Capture Influenza A Virus
- (2013) Gabriel L. Hendricks et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structurally Conserved Binding Sites of Hemagglutinin as Targets for Influenza Drug and Vaccine Development
- (2013) Muhammad Yusuf et al. Journal of Chemical Information and Modeling
- A Nanomolar Multivalent Ligand as Entry Inhibitor of the Hemagglutinin of Avian Influenza
- (2013) Moritz Waldmann et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Glycosylations in the Globular Head of the Hemagglutinin Protein Modulate the Virulence and Antigenic Properties of the H1N1 Influenza Viruses
- (2013) R. A. Medina et al. Science Translational Medicine
- Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza
- (2013) M. P. Limberis et al. Science Translational Medicine
- Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin
- (2013) Jie Yang et al. Viruses-Basel
- Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus
- (2013) Mayo Yasugi et al. PLoS Pathogens
- A novel family of peptides with potent activity against influenza A viruses
- (2012) M. Q. Nicol et al. JOURNAL OF GENERAL VIROLOGY
- A Phase II Study of DAS181, a Novel Host Directed Antiviral for the Treatment of Influenza Infection
- (2012) R. B. Moss et al. JOURNAL OF INFECTIOUS DISEASES
- Cross-neutralization of influenza A viruses mediated by a single antibody loop
- (2012) Damian C. Ekiert et al. NATURE
- An Induced Pocket for the Binding of Potent Fusion Inhibitor CL-385319 with H5N1 Influenza Virus Hemagglutinin
- (2012) Runming Li et al. PLoS One
- Molecular basis of the structure and function of H1 hemagglutinin of influenza virus
- (2012) Nongluk SRIWILAIJAROEN et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity
- (2012) P. S. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly Conserved Protective Epitopes on Influenza B Viruses
- (2012) C. Dreyfus et al. SCIENCE
- Influenza Virus-Mediated Membrane Fusion: Determinants of Hemagglutinin Fusogenic Activity and Experimental Approaches for Assessing Virus Fusion
- (2012) Brian S. Hamilton et al. Viruses-Basel
- Aprotinin and similar protease inhibitors as drugs against influenza
- (2011) O.P. Zhirnov et al. ANTIVIRAL RESEARCH
- CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry
- (2011) Shuwen Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mutagenesis of Surfactant Protein D Informed by Evolution and X-ray Crystallography Enhances Defenses against Influenza A Virusin Vivo
- (2011) Erika Crouch et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Capturing a Fusion Intermediate of Influenza Hemagglutinin with a Cholesterol-conjugated Peptide, a New Antiviral Strategy for Influenza Virus
- (2011) Kelly K. Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Characterization of the Hemagglutinin Receptor Specificity from the 2009 H1N1 Influenza Pandemic
- (2011) R. Xu et al. JOURNAL OF VIROLOGY
- Inhibition of Influenza A Virus (H1N1) Fusion by Benzenesulfonamide Derivatives Targeting Viral Hemagglutinin
- (2011) Lei Zhu et al. PLoS One
- Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin
- (2011) J. R. R. Whittle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin
- (2011) S. J. Fleishman et al. SCIENCE
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
- (2011) D. C. Ekiert et al. SCIENCE
- Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection
- (2011) Mahmoud M Bahgat et al. Virology Journal
- Networks link antigenic and receptor-binding sites of influenza hemagglutinin: Mechanistic insight into fitter strain propagation
- (2011) Venkataramanan Soundararajan et al. Scientific Reports
- Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181
- (2010) Gallen B. Triana-Baltzer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- NF- B RelA Subunit Is Crucial for Early IFN- Expression and Resistance to RNA Virus Replication
- (2010) J. Wang et al. JOURNAL OF IMMUNOLOGY
- Sialidase‐Based Anti–Influenza Virus Therapy Protects against Secondary Pneumococcal Infection
- (2010) Maria Hedlund et al. JOURNAL OF INFECTIOUS DISEASES
- Sialic Acid-Mimic Peptides As Hemagglutinin Inhibitors for Anti-Influenza Therapy
- (2010) Teruhiko Matsubara et al. JOURNAL OF MEDICINAL CHEMISTRY
- New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets
- (2010) Robert H. E. Friesen et al. PLoS One
- Pre‐ and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir
- (2009) Wouter Koudstaal et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibition of Influenza Virus Infections by Sialylgalactose-Binding Peptides Selected from a Phage Library
- (2009) Teruhiko Matsubara et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein
- (2009) Gallen B. Triana-Baltzer et al. PLoS One
- Antibody Recognition of a Highly Conserved Influenza Virus Epitope
- (2009) D. C. Ekiert et al. SCIENCE
- MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition
- (2009) Eva Böttcher et al. VACCINE
- Cross-Protective Potential of a Novel Monoclonal Antibody Directed against Antigenic Site B of the Hemagglutinin of Influenza A Viruses
- (2009) Reiko Yoshida et al. PLoS Pathogens
- Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N
- (2008) D SMEE et al. ANTIVIRAL RESEARCH
- Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol
- (2008) Irina A. Leneva et al. ANTIVIRAL RESEARCH
- Comment on: Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza
- (2008) J. M. Nicholls et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- SOCS-1 Mimetics Protect Mice against Lethal Poxvirus Infection: Identification of a Novel Endogenous Antiviral System
- (2008) C. M. Ahmed et al. JOURNAL OF VIROLOGY
- Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
- (2008) Mark Throsby et al. PLoS One
- Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
- (2008) R. J. Russell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started